Diamonds and Dogs
10/28/14Receptos Inc. (RCPT)
Receptos Inc. is making its investors happy today, up 37.50% to $93.14. The biopharmaceutical company saw its shares soar after its bowel-disease drug succeeded in its mid-stage trial. RPC1063 had proven significantly better than a placebo in patients with ulcerative colitis (UC), a disease involving inflammation and ulcers in the colon. 58% of the patients had a positive response to the drug and 16% were in clinical remission. Shares of Receptos hit a new 52-week high of $102.60 intraday.
Twitter Inc. (TWTR)
Twitter is getting negative tweets today, down 8.62% to $44.38. The social media company saw its shares fall after missing on earnings. For the quarter, management announced a large increase in revenue; up 114% to $361.3 million. However, the large increase was not enough to cover their massive costs and expenses of $510.8 million, causing the company to be in the red for the quarter. Furthermore, Twitter's user growth slowed by nearly 2% quarter over quarter causing concerns about future user growth.